These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30395748)

  • 1. Cross-sectional survey study to examine underuse of twice daily inhaled maintenance therapy among patients with asthma.
    Stanford RH; Bell C; Nag A; Johnson PT; Johnson MP; Watkins A
    J Asthma; 2019 Nov; 56(11):1172-1181. PubMed ID: 30395748
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma patients' self-reported behaviours toward inhaled corticosteroids.
    Laforest L; El Hasnaoui A; Pribil C; Ritleng C; Osman LM; Schwalm MS; Le Jeunne P; Van Ganse E
    Respir Med; 2009 Sep; 103(9):1366-75. PubMed ID: 19398316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the effect of beliefs about asthma medication and treatment intrusiveness on adherence and preference for once-daily vs. twice-daily medication.
    Chapman S; Dale P; Svedsater H; Stynes G; Vyas N; Price D; Horne R
    NPJ Prim Care Respir Med; 2017 Nov; 27(1):61. PubMed ID: 29138431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At what age do children start taking daily asthma medicines on their own?
    Orrell-Valente JK; Jarlsberg LG; Hill LG; Cabana MD
    Pediatrics; 2008 Dec; 122(6):e1186-92. PubMed ID: 19047221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing inhaled medications reported by adolescents with persistent asthma and their caregivers.
    Frey SM; Jones MR; Goldstein NPN; Fagnano M; Halterman JS
    J Asthma; 2020 Sep; 57(9):999-1005. PubMed ID: 31264485
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.
    Baker JW; Mellon M; Wald J; Welch M; Cruz-Rivera M; Walton-Bowen K
    Pediatrics; 1999 Feb; 103(2):414-21. PubMed ID: 9925834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health literacy among asthma patients and treatment expectations: results of a Belgian survey.
    Dupont L; Pilette C; Schleich F; Joos G
    Acta Clin Belg; 2020 Apr; 75(2):141-148. PubMed ID: 30638161
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.
    Hall IP; Fowler AV; Gupta A; Tetzlaff K; Nivens MC; Sarno M; Finnigan HA; Bateman ED; Rand Sutherland E
    Pulm Pharmacol Ther; 2015 Jun; 32():37-44. PubMed ID: 25861737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study.
    Price D; Lee AJ; Sims EJ; Kemp L; Hillyer EV; Chisholm A; von Ziegenweidt J; Williams A
    Prim Care Respir J; 2013 Jun; 22(2):161-8. PubMed ID: 23460035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
    Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
    Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.
    Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM
    BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
    Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence barriers to inhaled medicines in Japanese older patients with asthma evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) questionnaire.
    Sasaki J; Kawayama T; Yoshida M; Takahashi K; Fujii K; Machida K; Kinoshita T; Hoshino T;
    J Asthma; 2019 Jun; 56(6):632-641. PubMed ID: 29969920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.